Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Atheronova, Inc. (OTC: AHROQ).

Full DD Report for AHROQ


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-190.00550.00550.00550.005528,000
2018-04-180.0180.00550.0180.00558,000
2018-04-17N/A0.0055N/AN/A0
2018-04-16N/A0.0055N/AN/A0
2018-04-15N/A0.0055N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-1910,00028,00035.7143Short
2018-04-187,5008,00093.7500Short
2018-03-20100100100.0000Short
2018-02-261,0001,30076.9231Short
2018-02-2216,51125,21165.4913Short

* Short Mode

Short Analysis provided by Squeeze Report.


About Atheronova, Inc. (OTC: AHROQ)

Logo for Atheronova, Inc. (OTC: AHROQ)

AtheroNova Inc. is a clinical stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. Atherosclerotic plaque, which progressively narrows and blocks arteries, is the main underlying pathology of cardiovascular disease and the leading killer in industrialized nations worldwide. The Company s focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi billion dollar prescription drug market: cardiovascular disease and stroke prevention. Key Investment Considerations Billion market potential Strong IP protection Identifiable milestones Potentially lower risk of safety or efficacy problems than is typical in drug development Strong management team with successful track record Capital structure

 

Contact Information

 

 

Current Management

  • Thomas Gardner / CEO
  • Mark Selawski / CFO, Secretary
  • Louis Wharton, Esq. / Counsel
  • Thomas Gardner / Chairman
  • Paul DiPerna /
  • Fred Knoll /
  • Alexander Polinsky /
  • Boris Ratiner /
  • Johan M. Spoor /
  • Thijs Spoor /

Current Share Structure

  • Market Cap: $48,450 - 03/16/2018
  • Authorized: 100,000,000 - 11/05/2014
  • Issue and Outstanding: 8,809,139 - 11/05/2014
  • Float: 5,417,704 - 11/05/2014

 


Recent Filings from (OTC: AHROQ)

Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2016
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 08 2016

 

 


Daily Technical Chart for (OTC: AHROQ)

Daily Technical Chart for (OTC: AHROQ)


Stay tuned for daily updates and more on (OTC: AHROQ)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AHROQ)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AHROQ is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of AHROQ and does not buy, sell, or trade any shares of AHROQ. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us